NCT05731258
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +8 more
- Locations
-
- Second Affiliate Hospital of Zhejiang University Hangzhou, Zhejiang, China
Clinical trial condition
Liposomal Doxorubicin
Explore clinical trials studying Liposomal Doxorubicin. Study availability and eligibility vary by location and protocol.
3 public trials
1 recruiting study
Liposomal Doxorubicin trial results
Not Yet Recruiting
Efficacy and Safety of a Two-week Dosing Regimen of Vinorelbine Combined with Liposomal Doxorubicin in the Treatment of HER2-negative Advanced Breast Cancer
NCT06653972
- Conditions
- HER2-negative Metastatic Breast Cancer, Liposomal Doxorubicin, Vinorelbine
- Locations
-
Not specified
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +13 more
- Locations
-
Not specified